Antibodies
9 January 2007
Ablynx and Boehringer Ingelheim sign $265 million research and licensing agreement to develop new Alzheimer’s treatments9 January 2007
Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-409 January 2007
Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics9 January 2007
Antibody-Company f-star Raises EUR1.5 Million in Seed Financing Round From Atlas Venture6 January 2007
DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody ProductionNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports